Alphabet (GOOGL.US) subsidiary Waymo reportedly plans to expand its fleet to 20,000 vehicles by the end of next year, with a goal to double to 8,000 vehicles by the end of this year.
According to reports, Waymo plans to expand its fleet fivefold, reaching 20,000 vehicles.
According to information from insiders cited by Zhihui Finance APP, Alphabet’s (GOOGL.US) autonomous driving unit Waymo plans to expand its fleet to five times its current size, reaching 20,000 vehicles by the end of next year, using funds raised from a $5 billion loan earlier this month.
It is reported that this ride-hailing autonomous vehicle service provider currently owns 4,000 vehicles, and plans to first expand to 8,000 vehicles by the end of this year, and further increase to 20,000 vehicles by the end of next year. Waymo currently operates in 15 cities in the United States, and has announced plans to launch ride services in London, Tokyo, Singapore, and Canada.
Earlier this month, Waymo secured a $5 billion loan from lenders including PIMCO, Blackstone, and Sixth Street, stating that it will use the funds to expand its services across the United States and into international markets. Earlier this year, the company completed a $16 billion equity financing round, with a valuation of $126 billion at that time.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Crypto prices
More
